Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$792K Buy
1,879
+151
+9% +$60.2K 0.32% 72
2026
Q2
$626K Buy
1,728
+75
+5% +$25.7K 0.29% 90
2026
Q1
$582K Buy
1,653
+267
+19% +$95.2K 0.33% 87
2025
Q4
$454K Buy
+1,386
New +$440K 0.28% 96

Other funds holding AMGN

XXI Wealth's AMGN Position: Q3 2026 in Review

XXI Wealth increased its Amgen (AMGN) stake by 8.7% in Q3 2026, buying an estimated $60.2K and bringing the position to 1,879 shares worth $792K. The position accounts for 0.32% of the portfolio, ranked #72.

XXI Wealth first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,948 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • XXI Wealth held 1,879 shares of Amgen worth $792K as of Q3 2026.
  • XXI Wealth bought 151 Amgen shares in Q3 2026, an estimated $60.2K.
  • Amgen made up 0.32% of XXI Wealth's portfolio in Q3 2026, its #72 holding.
  • XXI Wealth first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 2,948 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.